Login
Toggle navigation
Videos
Categories
Trending
Accelerator composed of 1800 serial entrepreneurs industry experts|Joseph Huang,CEO,StartX
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Stanford CS Alum, ex-Founder of WiFiSLAM.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Intrepid Metals Reports Strong Drill Results at Corral Copper Property
00:10:00
Green Energy Strategy Unveiled: Ignito's Group Aims for 100% Renewable Power in Europe by 2050| Darius Maikštenas, CEO, Ignitis Grupe AB.
00:10:00
Australian Nickel and Exploration Company Overview
00:10:00
Severn Trent's Financial Performance and Social Purpose Initiatives Set the Stage for a Bright Future Ahead | Liv Garfield, Managing Director ,Severn Trent PLC.
00:10:00
Adapting to Economic Shifts: Strategies for High Inflation and Interest Rates | Euan Munro , CEO , Newton Investment Management .
00:10:00
Ursula M. Burns, former Chairman and CEO of Xerox Corporation and VEON Ltd., speaks with Bloomberg's Caroline.
00:10:00
Sebastián Kanovich on Overcoming Payment Challenges for Merchants | Sebastián Kanovich - CEO of dLocal
00:10:00
Bannerman Energy: Positioned for Uranium Market Surge with Fully Permitted Itango Project
00:10:00
Mutual of Omaha Advisors: Redefining Careers with Professional Growth and Personal Balance
00:10:00
Andrew Richards Discusses Big River Gold's Advancements and Future Plans in Northeastern Brazil
00:10:00
invest with fast commits and high conviction and they strive to be proactively helpful|Cindy Bi,General Partner,CapitalX
00:10:00
Relocating After Retirement: 3 Key Considerations | Ron Bernstein, Co-founder , Prism Planning Partners.